10-formyltetrahydrofolate dehydrogenase-induced c-Jun-NH2-kinase pathways diverge at the c-Jun-NH2-kinase substrate

Sampa Ghose1, Natalia V Oleinik, Natalia I Krupenko

  • 1Department of Biochemistry and Molecular Biology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC, USA.

Insights

10-Formyltetrahydrofolate dehydrogenase (FDH) triggers apoptosis in cancer cells via JNK and ERK pathways. While JNK activation is crucial for FDH-induced cytotoxicity, its downstream targets like c-Jun or p53 are cell-type specific.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • 10-Formyltetrahydrofolate dehydrogenase (FDH) exhibits dual roles in cancer, suppressing proliferation via p53-dependent apoptosis but inducing cytotoxicity in p53-deficient cells.
  • Understanding the precise molecular mechanisms underlying FDH-induced cytotoxicity is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To elucidate the signaling pathways involved in FDH-induced apoptosis in p53-deficient prostate cancer cells (PC-3).
  • To investigate the role of JNK and ERK pathways and their downstream targets in FDH-mediated cytotoxicity.
  • To compare the FDH-induced apoptotic mechanisms in p53-deficient and p53-proficient cancer cells.

Main Methods:

  • Utilized specific inhibitors (SP600125 for JNK, PD98059 for ERK) and siRNA knockdown to assess pathway involvement.
  • Employed dominant-negative mutants (TAM67) to investigate the role of c-Jun.
  • Performed pull-down assays to confirm direct protein-protein interactions.
  • Analyzed caspase activation (caspase 8 and 9) in different cell lines.

Main Results:

  • FDH induces apoptosis in PC-3 cells through simultaneous activation of JNK and ERK pathways.
  • JNK activation, leading to c-Jun phosphorylation, plays a more significant role than ERK in FDH-induced apoptosis in PC-3 cells.
  • In p53-proficient A549 cells, FDH activates JNK, but its downstream target is p53, not c-Jun.
  • FDH activates caspase 8 in PC-3 cells and caspase 9 in A549 cells.
  • High leucovorin supplementation inhibits FDH-induced JNK activation, suggesting a link between folate metabolism and MAPK pathways.

Conclusions:

  • JNK pathway activation is a conserved downstream mechanism of FDH-induced cytotoxicity across different cancer cell types.
  • The specific downstream targets of JNK (e.g., c-Jun, p53) and the activated caspase (caspase 8 or 9) are cell-type specific.
  • These findings highlight the intricate interplay between folate metabolism and MAPK signaling in cancer cell death.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...